Tristel announces Board member Dr Bruno Holthof as next Non-Executive Chairman

– UK, Snailwell –  Tristel plc (LON: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, today announced that Dr Bruno Holthof will take over the role of Non-Executive Chairman at the Company’s forthcoming Annual General Meeting.

Paul Swinney, CEO said: “I would like to thank Paul Barnes for his thoughtful stewardship of our Board over the past year. I am delighted that Dr Holthof has agreed to take up the position of Chair, bringing his broad experience of global healthcare to our Company. In the New Year, we shall begin a selection process for an additional Independent Non-Executive Director.”

About Dr Bruno Holthof

Dr Holthof joined the Board of Tristel in February 2019 as an Independent Non-Executive Director. Having spent ten months familiarising himself with the Company he will take over the position of Non-Executive Chairman from Paul Barnes at the 2019 AGM. Paul Barnes has provided interim cover in the role, after Francisco Soler stepped down in December 2018. Paul Barnes will remain a Non-Executive Director of the Company.

The Board will now begin the search for a third Independent Non-Executive Director to maintain an appropriate balance between executive and non-executive directors as detailed in the QCA guidelines on Board composition.

Dr Holthof commented: “As I step up to the Chairman role, my primary focus will be to work with my Board colleagues to ensure the Company continues to deliver upon its strategic goals, whilst safeguarding the unique character of this excellent business. I look forward to the future with great enthusiasm.”

For more information: https://www.tristel.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.